Pre-Emptive OCT-Guided Angioplasty of Vulnerable Intermediate Coronary Lesions: Results from the Prematurely Halted PECTUS-Trial

Table 1

Inclusion and exclusion criteria.

Inclusion criteria	Exclusion criteria
Clinical	Clinical
(i) Age ≥18 years	(i) Pregnancy
(ii) Clinical presentation of STEMI or NSTEMI	(ii) Severe kidney disease defined as an eGFR <30 ml/min
	(iii) Previous CABG
	(iv) Indication for revascularization by CABG
	(v) Estimated life expectancy <1 year
Angiographical	Angiographical
(i) Presence of residual, intermediate CAD (diameter stenosis of 30–90%), with the possibility of plaque vulnerability	(i) Target vessel diameter <2.5 mm or >4.0 mm
	(ii) Anatomy of lesion unsuitable for OCT catheter crossing or imaging (aorta-ostial lesions, small diameter segment, and severe calcifications)
	(iii) Anatomy unsuitable for BVS placement (left main, bifurcation, and side branch (>2 mm) involvement)
	(iv) Target lesion is
	(a) In-stent restenosis
	(b) Chronic total occlusion
	(c) In the same vessel as treated culprit lesion
	(d) In the same segment as a previously implanted stent/scaffold

BVS, bioresorbable vascular scaffold, CABG, coronary artery bypass grafting, CAD, coronary artery disease, NSTEMI, Non-ST-elevation myocardial infarction, OCT, optical coherence tomography, STEMI, ST-elevation myocardial infarction.